Effectiveness of high dose chemoradiotherapy and autologous stem cell transplantation for patients with biopsy-proven primary refractory Hodgkin's disease

British Journal of Haematology

Volumn 124, Issue 5, 2004, Pages 645-652

  Moskowitz, Craig H ^a   Kewalramani, Tarun ^a   Nimer, Stephen D ^a   Gonzalez, Maria ^a   Zelenetz, Andrew D ^a   Yahalom, Joachim ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

ASCT; Biopsy proven; Chemosensitive; Hodgkin's Disease; Refractory

Indexed keywords

BLEOMYCIN; CARMUSTINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; PREDNISONE; PROCARBAZINE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER CENTER; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMOSENSITIVITY; CONTROLLED STUDY; DRUG MEGADOSE; FOLLOW UP; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RADIATION DOSE; SCHOOL CHILD; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR BIOPSY;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 1542359509     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2003.04828.x     Document Type: Article

References (34)

1. Andre, M., Henry-Amar, M., Pico, J.L., Brice, P., Blaise, D., Kuentz, M., Coiffier, B., Colombat, P., Cahn, J.Y., Attal, M., Fleury, J., Milpied, N., Nedellec, G., Biron, P., Tilly, H., Jouet, J.P. & Gisselbrecht, C. (1999) Comparison of high-dose therapy and autologous stem-cell transplantation with conventional therapy for Hodgkin's disease induction failure: a case-control study. Societe Francaise de Greffe de Moelle. Journal of Clinical Oncology, 17, 222-229.
2. Bakheet, S.M., Powe, J., Ezzat, A. & Rostom, A. (1998) F-18-FDG uptake in tuberculosis. Clinical Nuclear Medicine, 23, 739-742.
3. Bodis, S., Henry-Amar, M., Bosq, J., Burgers, J.M., Mellink, W.A., Dietrich, P.Y., Dupouy, N., Noordijk, E.M., Raemaekers, J.M., Thomas, J., Eghbali H., Regnier R., Tanguy A., Vedonck L., Michel J., Zittoun R., Kerkhofs H. & Hayat M. (1993) Late relapse in early-stage Hodgkin's disease patients enrolled on European Organization for Research and Treatment of Cancer protocols. Journal of Clinical Oncology, 11, 225-232.
4. Bonfante, V., Santoro, A., Viviani, S., Devizzi, L., Balzarotti, M., Soncini, F., Zanini, M., Valagussa, P. & Bonadonna, G. (1997) Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD. Journal of Clinical Oncology, 15, 528-534.
5. Buckanovich, R.J., Liu, G., Stricker, C., Luger, S.M., Stadtmauer, E.A., Schuster, S.J., Duffy, K., Tsai, D., Pruitt, A. & Porter, D.L. (2002) Nonmyeloablative allogeneic stem cell transplantation for refractory Hodgkin's lymphoma complicated by interleukin-2 responsive progressive multifocal leukoencephalopathy. Annals of Hematology, 81, 410-413.
6. Canellos, G.P. (2002) Primary treatment of Hodgkin's disease. Annals of Oncology, 13(Suppl. 4), 153-158.
7. Cox (1972) Regression models and life tables. Journal of Royal Statistical Society, London Series B, 34, 187-202.
8. Diehl, V. & Josting, A. (2000) Hodgkin's disease. Cancer Journal, 6(Suppl. 2), S150-S158.
9. Diehl, V., Sieber, M., Ruffer, U., Lathan, B., Hasenclever, D., Pfreundschuh, M., Loeffler, M., Lieberz, D., Koch, P., Adler, M. & Tesch, H., The German Hodgkin's Lymphoma Study Group (1997) BEA-COPP: an intensified chemotherapy regimen in advanced Hodgkin's disease. Annals of Oncology, 8, 143-148.
10. Epelbaum, R., Ben-Arie, Y., Bar-Shalom, R., Gaitini, D., Ben-Shahar, M., Leviov, M., Ben-Haim, S., Israel, O., Front, D. & Haim, N. (1997) Benign proliferative lesions mimicking recurrence of Hodgkin's disease. Medical and Pediatric Oncology, 28, 187-190.
11. Ferme, C., Mounier, N., Divine, M., Brice, P., Stamatoullas, A., Reman, O., Voillat, L., Jaubert, J., Lederlin, P., Colin, P., Berger, F. & Salles, G. (2002) Intensive salvage therapy with high-dose chemotherapy for patients with advanced Hodgkin's disease in relapse or failure after initial chemotherapy: results of the Groupe d'Etudes des Lymphomes de l'Adulte H89 Trial. Journal of Clinical Oncology, 20, 467-175.
12. Gargot, D., Algayres, J.P., Brunet, C., L'Her, P., Valmary, J.P., Maurel, C. & Daly, J.P. (1990) Sarcoidosis and sarcoid reaction associated with Hodgkin's disease. Revue de Medecine Interne, 11, 157-160.
13. Grosskreutz, C., Ross, V., Scigliano, E., Fruchtman, S. & Isola, L. (2003) Low-dose total body irradiation, fludarabine, and antithymocyte globulin conditioning for nonmyeloablative allogeneic transplantation. Biology of Blood and Marrow Transplantation, 9, 453-459.
14. Josting, A., Reiser, M., Rueffer, U., Salzberger, B., Diehl, V. & Engert, A. (2000) Treatment of primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma: is there a chance for cure? Journal of Clinical Oncology, 18, 332-339.
15. Kaplan, E. & Meier P. (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457-481.
16. Lazarus, H.M., Rowlings, P.A., Zhang, M.J., Vose, J.M., Armitage, J.O., Bierman, P.J., Gajewski, J.L., Gale, R.P., Keating, A., Klein, J.P., Miller, C.B., Phillips, G.L., Reece, D.E., Sobocinski, K.A., van Besien, K. & Horowitz, M.M. (1999) Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. Journal of Clinical Oncology, 17, 534-545.
17. Linch, D.C., Winfield, D., Goldstone, A.H., Moir, D., Hancock, B., McMillan, A., Chopra, R., Milligan, D. & Hudson, G.V. (1993) Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNL1 randomised trial. Lancet, 341, 1051-1054.
18. Lister, T.A., Crowther, D., Sutcliffe, S.B., Glatstein, E., Canellos, G.P., Young, R.C., Rosenberg, S.A., Coltman, C.A. & Tubiana, M. (1989) Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. Journal of Clinical Oncology, 7, 1630-1636.
19. Longo, D.L., Duffey, P.L., Young, R.C., Hubbard, S.M., Ihde, D.C., Glatstein, E., Phares, J.C., Jaffe, E.S., Urba, W.J. & DeVita, Jr, V.T. (1992) Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure. Journal of Clinical Oncology, 10, 210-218.
20. Maloney, G.D. (2000) Monoclonal antibodies in lymphoid neoplasia: principles for optimal combined therapy. Seminars in Hematology, 37, 17-26.
21. Moskowitz, C. (2002) Risk-adapted therapy for relapsed and refractory lymphoma using ICE chemotherapy. Cancer Chemotherapy and Pharmacology, 49 (Suppl. 1), S9-S12.
22. Moskowitz, C.H., Nimer, S.D., Zelenetz, A.D., Trippett, T., Hedrick, E.E., Filippa, D.A., Louie, D., Gonzales, M., Walits, J., Coady-Lyons, N., Qin, J., Frank, R., Bertino, J.R., Goy, A., Noy, A., O'Brien, J.P., Straus, D., Portlock, C.S. & Yahalom, J. (2001) A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model. Blood, 97, 616-623.
23. Press, O.W., Eary, J.F., Gooley, T., Gopal, A.K., Liu, S., Rajendran, J.G., Maloney, D.G., Petersdorf, S., Bush, S.A., Durack, L.D., Martin, P.J., Fisher, D.R., Wood, B., Borrow, J.W., Porter, B., Smith, J.P., Matthews, D.C., Appelbaum, F.R. & Bernstein, I.D. (2000) A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas. Blood, 96, 2934-2942.
24. Reece, D.E., Barnett, M.J., Shepherd, J.D., Hogge, D.E., Klasa, R.J., Nantel, S.H., Sutherland, H.J., Klingemann, H.G., Fairey, R.N., Voss, N.J. (1995) High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/-P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy. Blood, 86, 451-456.
25. Schmitz, N., Pfistner, B., Sextro, M., Sieber, M., Carella, A.M., Haenel, M., Boissevain, F., Zschaber, R., Muller, P., Kirchner, H., Lohri, A., Decker, S., Koch, B., Hasenclever, D., Goldstone, A.H. & Diehl, V. (2002) Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial. Lancet, 359, 2065-2071.
26. Simsek, S., van Leuven, F., Bronsveld, W., Ooms, G.H., Groeneveld, A.B. & de Graaff, C.S. (2002) Unusual association of Hodgkin's disease and sarcoidosis. Netherlands Journal of Medicine, 60, 438-440.
27. Slavin, S., Nagler, A., Naparstek, E., Kapelushnik, Y., Aker, M., Cividalli, G., Varadi, G., Kirschbaum, M., Ackerstein, A., Samuel, S., Amar, A., Brautbar, C., Ben-Tal, O., Eldor, A. & Or, R. (1998) Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood, 91, 756-763.
28. Sweetenham, J.W., Carella, A.M., Taghipour, G., Cunningham, D., Marcus, R., Della Volpe, A., Linch, D.C., Schmitz, N. & Goldstone, A.H. (1999) High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: results in 175 patients reported to the European Group for Blood and Marrow Transplantation. Lymphoma Working Party. Journal of Clinical Oncology, 17, 3101-3109.
29. Wirth, A., Corry, J., Laidlaw, C., Matthews, J. & Liew, K.H. (1997) Salvage radiotherapy for Hodgkin's disease following chemotherapy failure. International Journal of Radiation Oncology, Biology, Physics, 39, 599-607.
30. Witzig, T.E. (2001) Radioimmunotherapy for patients with relapsed B-cell non-Hodgkin lymphoma. Cancer Chemotherapy and Pharmacology, 48(Suppl. 1), S91-S95.
31. Yahalom, J. (1995a) Integrating radiotherapy into bone marrow transplantation programs for Hodgkin's disease. International Journal of Radiation Oncology, Biology, Physics, 33, 525-528.
32. Yahalom, J. (1995b) High-dose chemotherapy and radiotherapy with bone marrow transplantation in the management of the non-Hodgkin's lymphomas. Seminars in Radiation Oncology, 5, 316-330.
33. Yahalom, J. (1997) Do not miss a second (and possibly last) chance to cure Hodgkin's disease. International Journal of Radiation Oncology, Biology, Physics, 39, 595-597.
34. Yahalom, J., Gulati, S.C., Toia, M., Maslak, P., McCarron, E.G., O'Brien, J.P., Portlock, C.S., Straus, D.J., Phillips, J. & Fuks, Z. (1993) Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's disease. Journal of Clinical Oncology, 11, 1062-1070.